On occasion we have had differences in performance returns for the same
analyte using the 2 schemes. The standard response to investigation is 'Its
OK on the other scheme, so whats the problem?'. Is there any data on
characteristics of samples distributed or stability of samples between the
2 schemes?
Thatnk
Michael Ryan
=======================================================================
This e-mail may have been sent by the author as a personal communication
and the views and comments expressed herein are not necessarily
reflective of the policies or opinions of United Hospital HSS Trust. This
message may contain information which is legally privileged and/or
confidential. If you are not the intended recipient, you are notified that
any unauthorised disclosure, copying, distribution or use of this
information is strictly prohibited. If you have received this message in
error, please notify us by telephoning +44-(0)2894-424535 immediately
during United Kingdom business hours, or by e-mailing us at
[log in to unmask]
=======================================================================
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|